6 studies found for:    19706858 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Clopidogrel PGX Bench to Bedside
Condition: Metabolism of Clopidogrel
Intervention: Drug: Clopidogrel, Omeprazole
2 Active, not recruiting Pharmacogenomics and Effective Treatment With Clopidogrel
Condition: Pharmacogenomics
Intervention: Genetic: Pharmacogenomics
3 Terminated Pharmacogenomics of Anti-platelet Intervention-2 (PAPI-2) Study
Conditions: Cardiovascular Diseases;   Acute Coronary Syndrome
Interventions: Drug: clopidogrel;   Drug: prasugrel
4 Recruiting Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
Condition: Acute Coronary Syndrome
Interventions: Drug: Clopidogrel;   Drug: Ticagrelor
5 Unknown  Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin
Condition: Coronary Artery Disease
Intervention: Drug: Bivalirudin with and without eptifibatide
6 Unknown  Determining Genetic Role in Treatment Response to Anti-Platelet Interventions (The PAPI Study)
Conditions: Platelet Aggregation Inhibitors;   Coronary Heart Disease
Interventions: Drug: Clopidogrel;   Drug: Aspirin

Indicates status has not been verified in more than two years